Understanding Sugar-Sweetened Beverages (SSB) and Colorectal Cancer (CRC)
NCT ID: NCT06669923
Last Updated: 2024-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2024-11-15
2030-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evidence Based Colorectal Cancer Screening for the Uninsured - Sub-study
NCT02651974
Promoting CRC Screening in an Urban Minority Population
NCT02392143
Colon Cancer Prevention Study
NCT00924690
Increasing Colorectal Cancer Screening in Urban African American Communities Via Churches
NCT01139242
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans
NCT03640208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline
Baseline study collects baseline data and screens for potential participants for the follow-up study.
No interventions assigned to this group
Follow Up - Patient Education Group
Patient Education
website with information about cancer screening and prevention (e.g. screening tests for seven types of cancer)
Follow Up - iSIPsmarter Program Group
iSIPsmarter Program
web-based behavioral intervention to reduce sugary drink intake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iSIPsmarter Program
web-based behavioral intervention to reduce sugary drink intake
Patient Education
website with information about cancer screening and prevention (e.g. screening tests for seven types of cancer)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients 18+
* Regular access (\<1/week) to the internet.
* Drink more than recommended amount of sugar-sweetened beverages per day (assessed from participant's responses to the Beverage Questionnaire section (BEVQ-15) of the Computer Administered Phone Interview (CAPI), from the Baseline study).
Exclusion Criteria
* Subjects diagnosed with inflammatory bowel disorder
* Subjects diagnosed with cancer (except non-melanoma skin cancer)
* Subjects taking blood thinners at time of colonoscopy (except 325 mg daily aspirin)
Follow-up Study:
In order to be eligible to participate in the f/up study, an individual must meet all of the criteria for the Baseline study AND:
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Virginia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Li
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Li, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UVA, Dept of Family Medicine
Jamie Zoellner, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
UVA, Dept of Public Health Sciences
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSR230101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.